Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study

Everett E. Vokes, Francoise Mornex, Ahmet Sezer, Ying Cheng, Jian Fang, David Vicente Baz, Timucin Cil, Alex A. Adjei, Myung Ju Ahn, Fabrice Barlesi, Enriqueta Felip, Edward B. Garon, Francois Audhuy, Rena Ito, Masashi Sato, S. Peter Eggleton, Claudio Marcelo Martin, Martin Reck, Clifford G. Robinson, Luis Paz-Ares

Research output: Contribution to journal › Article › peer-review

Fingerprint

Dive into the research topics of 'Bintrafusp Alfa With CCRT Followed by Bintrafusp Alfa Versus Placebo With CCRT Followed by Durvalumab in Patients With Unresectable Stage III NSCLC: A Phase 2 Randomized Study'. Together they form a unique fingerprint.

Medicine & Life Sciences